Cost effectiveness ratio: an often misunderstood term

Comment

T J Gan et al. Anesth Analg. 1999 May.

. 1999 May;88(5):1191-2.

doi: 10.1097/00000539-199905000-00052.

No abstract available

Comment on

A comparison of costs and efficacy of ondansetron and droperidol as prophylactic antiemetic therapy for elective outpatient gynecologic procedures.
Tang J, Watcha MF, White PF. Tang J, et al. Anesth Analg. 1996 Aug;83(2):304-13. doi: 10.1097/00000539-199608000-00018. Anesth Analg. 1996. PMID: 8694310 Clinical Trial.
The effect of timing of ondansetron administration on its efficacy, cost-effectiveness, and cost-benefit as a prophylactic antiemetic in the ambulatory setting.
Tang J, Wang B, White PF, Watcha MF, Qi J, Wender RH. Tang J, et al. Anesth Analg. 1998 Feb;86(2):274-82. doi: 10.1097/00000539-199802000-00010. Anesth Analg. 1998. PMID: 9459232 Clinical Trial.